INHIBITEURS DE PDK1 HETEROCYCLIQUES DESTINES A ETRE UTILISES POUR TRAITER LE CANCER

• 收藏
• 分享

专利权人:

INC.;SUNESIS PHARMACEUTICALS

发明人:

HANSEN, STIG K.,BINNERTS, MINKE E.

申请号：

CA3002907

公开号：

CA3002907A1

申请日:

2016.10.21

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

Described are methods of use of compounds that inhibit PIF -mediated substratebinding by PDK1, which are usefulas inhibitors of cancer growth or proliferation that is RSK2-dependent or AKT-independent. Also described are compositions ofsuch compounds for use in such methods of treating cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/